GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,901,000 | +95.4% | 33,801 | +64.9% | 0.80% | +102.3% |
| Q3 2020 | $1,996,000 | -82.9% | 20,501 | -78.4% | 0.40% | -88.4% |
| Q2 2020 | $11,656,000 | -20.8% | 94,984 | -43.5% | 3.40% | -31.0% |
| Q1 2020 | $14,716,000 | -24.2% | 168,044 | -9.5% | 4.93% | +6.6% |
| Q4 2019 | $19,423,000 | -6.0% | 185,757 | +3.4% | 4.63% | -30.5% |
| Q3 2019 | $20,673,000 | -3.4% | 179,714 | +44.7% | 6.66% | +29.0% |
| Q2 2019 | $21,405,000 | +12.4% | 124,164 | +9.9% | 5.16% | +0.4% |
| Q1 2019 | $19,046,000 | +132.3% | 112,986 | +34.2% | 5.14% | +72.2% |
| Q4 2018 | $8,199,000 | +447.0% | 84,186 | +683.9% | 2.99% | +260.2% |
| Q2 2018 | $1,499,000 | -40.2% | 10,740 | -43.5% | 0.83% | -41.4% |
| Q4 2017 | $2,508,000 | – | 19,000 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |